加州太平洋生物科学公司 PACB 深 沪
已收盘 05-15 16:00:00 美东时间
1.12
-0.090
-7.44%
华盛通- 最 高1.21
- 今 开1.21
- 成交量 930.76万股
- 最 低 1.12
- 昨 收 1.21
- 总市值 3.48亿
- 52周最高 2.73
- 市盈率 静 --
- 换手率 3.00%
- 52周最低 0.8511
- 委 比 -9.53%
- 总股本 3.10亿
- 历史最高 53.69
- 量 比 1.29
- 振 幅 7.44%
- 历史最低 0.8511
- 每 手 1
- 风险率 0.39%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | Arxis、Madison Air获多家大行首予买入评价！潜在涨幅441.87%！Caribou Biosciences获HC Wainwright & Co.升目标价至11美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从9美元升至11美元；康托·菲茨杰拉德：维持Artiva Biotherapeutics"超配"评级，目标价从10美元升至40美元
05-12 12:36
Pacific Biosciences Balances Growth Hopes and Margin Strain
Pacific Biosciences (($PACB)) has held its Q1 earnings call. Read on for the ma...
05-09 08:52
Pacific Biosciences of California shares are trading lower after the company reported worse-than-expected Q1 sales results.
Pacific Biosciences of California shares are trading lower after the company re...
05-08 23:52
PacBio tumbles after narrowing full-year revenue guidance
Pacific Biosciences of California (PACB) shares fell 16% after the company reported Q1 results that included a wider-than-expected revenue miss and weaker profitability metrics. PacBio reported Q1 non...
05-08 22:51
Pacific Biosciences Sees FY2026 Sales $165.000M-$175.000M vs $173.371M Est
Pacific Biosciences (NASDAQ:PACB) sees FY2026 sales of $165.000 million-$175.000 million vs $173.371 million analyst estimate.
05-08 04:14
PacBio And PerkinElmer Subsidiary Covaris Announce That A Joint Workflow Has Been Developed For Robust HiFi Sequencing Of Formalin-Fixed, Paraffin-Embedded (FFPE) Tissue Samples
The protocol will be formally presented at the upcoming American Association for Cancer Research (AACR) Annual Meeting. This solution integrates Covaris' truXTRA FFPE extraction technology with PacBio's Kinnex™
04-15 21:15
Gitlab, Altimmune, Cheniere, Pacific Biosciences, Hercules Shock Wall Street
Insiders have been trading these 5 stocks: (($GTLB)), (($ALT)), (($LNG)), (($PA...
04-04 21:01
新浪财经ESG：Pacific Biosciences of Californi MSCI（明晟）ESG评级调降至B
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:27
美股大行评级 | 潜在涨幅183%！迈威尔科技获10家机构上调目标价最高至164美元；伯灵顿百货、好市多、Ciena、Samsara等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持BridgeBio Oncology"买入"评级，目标价从27美元升至29美元；韦德布什：维持WAVE Life Sciences"跑赢大市"评级，目标价从33美元升至35美元
03-09 11:47
Medpace, IQVIA upgraded at Barclays; says AI concerns are overdone
As part of a broader review of life science and diagnostic tools stocks, Barclays upgraded contract research organizations IQVIA Holdings (IQV) and Medpace Holdings (MEDP) on Friday, noting that conce...
03-07 02:44
